Human medicines European public assessment report (EPAR): Dazluma, troriluzole, Status: Application withdrawn

Human medicines European public assessment report (EPAR): Tecvayli, teclistamab, Date of authorisation: 23/08/2022, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Privigen, human normal immunoglobulin (IVIg), Date of authorisation: 24/04/2008, Revision: 33, Status: Authorised

ICH E22 General considerations for patient preference studies - Scientific guideline

Appendix 1: Acceptable intakes established for N-nitrosamines

Fee regulation working arrangements

Cookies

Human medicines European public assessment report (EPAR): Hemangiol, propranolol, Date of authorisation: 23/04/2014, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Evfraxy, denosumab, Date of authorisation: 30/06/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 75, Status: Authorised